Patent · US Expired

Antiemetic compositions

US5605928A · kind A · utility

11Cited by

0References

6Claims

0Family size

Assignee

YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. · IL

Inventors

Raphael Mechoulam · Jerusalem, IL
Abraham Abrahamov · Jerusalem, IL

Key dates

Filing date	Nov 30, 1994
Grant date	Feb 25, 1997
Priority date	—
Expiry date	Nov 30, 2014

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P1/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An antiemetic pharmaceutical composition for use in conjunction with oncoical chemitherapy. The composition is of special value in pediatric oncological medicine. The active ingredient is .DELTA.-8-tetrahydro-cannabinol, .DELTA.-8-THC. Average unit dosage forms for use in pediatric medicine contain from about 4 mg/m.sup.2 to about 20 mg/m.sup.2 of the active compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.